Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/17/25 21:17 | 1/17/25 | ADAP | Health | BioPrd | Biological Products, (No Diag | Norry Elliot | X0 | O | Chief Me | 2 | S.m | -16 | 0.5818 | 0 | -28 | 14 | D | |||||||||||||||
1/17/25 21:17 | 1/17/25 | ADAP | Health | BioPrd | Biological Products, (No Diag | Lunger John | X0 | O | Chief Pa | 2 | S.m | -15 | 0.5812 | 0 | -25 | 14 | D | |||||||||||||||
1/17/25 21:16 | 1/17/25 | ADAP | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | X0 | O | COO | 2 | S.m | -15 | 0.5812 | 0 | -25 | 14 | D | |||||||||||||||
1/17/25 21:15 | 1/17/25 | ADAP | Health | BioPrd | Biological Products, (No Diag | Rawcliffe Adrian | X0 | DO | CEO | 2 | S.m | -52 | 0.5813 | 0 | -90 | 44 | D | |||||||||||||||
1/15/25 16:18 | 1/15/25 | ADAP | Health | BioPrd | Biological Products, (No Diag | Piccina Cintia | X0 | O | Chief Co | 1 | S | -7 | 0.5748 | 0 | -13 | 18 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |